Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.89 EUR | -8.33% | -4.23% | -11.30% |
Sales 2024 * | 30.13M 32.8M 44.82M | Sales 2025 * | 51.2M 55.73M 76.17M | Capitalization | 277M 302M 413M |
---|---|---|---|---|---|
Net income 2024 * | -39M -42.45M -58.02M | Net income 2025 * | -23M -25.03M -34.22M | EV / Sales 2024 * | 9.21 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | 2.55 2.78 3.79 | EV / Sales 2025 * | 5.42 x |
P/E ratio 2024 * |
-6.95
x | P/E ratio 2025 * |
-16.2
x | Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.67% |
Latest transcript on Nanobiotix
1 day | -8.33% | ||
1 week | -4.23% | ||
Current month | -9.24% | ||
1 month | +0.17% | ||
3 months | -1.51% | ||
6 months | +15.04% | ||
Current year | -11.30% |
Managers | Title | Age | Since |
---|---|---|---|
Laurent Lévy
CEO | Chief Executive Officer | 53 | 03-03-03 |
Bart van Rhijn
DFI | Director of Finance/CFO | 52 | 21-05-31 |
Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
CHM | Chairman | 58 | 21-05-24 |
Enno Spillner
BRD | Director/Board Member | 55 | 14-06-17 |
Alain Herrera
BRD | Director/Board Member | 74 | 11-06-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 5.89 | -8.33% | 120,055 |
24-06-03 | 6.425 | -1.00% | 55,956 |
24-05-31 | 6.49 | +0.15% | 30,853 |
24-05-30 | 6.48 | +6.06% | 68,664 |
24-05-29 | 6.11 | -0.65% | 41,937 |
Real-time Euronext Paris, June 04, 2024 at 11:35 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.30% | 330M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- NANO Stock